Satellos Bioscience (MSLE) PE Ratio: History & Chart

Basis: FMP quote price / unrounded diluted EPS from four consecutive issuer fiscal quarters. Source: stored company filings and market data; unavailable inputs remain N/A.

The P/E ratio is N/A as of 2026-10-06T14:53:08.490Z.

Stored calculation inputs

Calculation as of: 2026-10-06T14:53:08.490Z.

Quote observation: 2026-10-06T14:49:07.000Z. Amounts in USD. The price header may show a later quote.

Quote price: 8.085
Unrounded diluted TTM EPS · period ending 2026-06-30: -1.92

FMP input reference: a92f25166a0617989281a7eefd332dc08894ee274fcedbd674fe1a92e2c9d78d

Forward PE Ratio|PEG Ratio|P/B Ratio|EPS|All Metrics

MSLE PE Ratio Metrics

PE RATIO

N/A

MSLE Competitors' PE Ratio

MSLE

Satellos Bioscience Inc.

Current

Market Cap

$10.42M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

LFWD

Lifeward Ltd.

vs MSLE

Market Cap

$10.47M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

LSTA

Lisata Therapeutics, Inc.

vs MSLE

Market Cap

$11.38M

PE Ratio

N/A

TTM Avg

2.09

3Y Avg

2.09

5Y Avg

2.09

GDTC

CytoMed Therapeutics Limited

vs MSLE

Market Cap

$11.00M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

CABR

Caring Brands, Inc.

vs MSLE

Market Cap

$10.09M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

MDCX

Medicus Pharma Ltd. Common Stock

vs MSLE

Market Cap

$10.06M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

MTVA

MetaVia Inc.

vs MSLE

Market Cap

$10.08M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

CNSY

Cerenome, Inc.

vs MSLE

Market Cap

$10.98M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

BIVI

BioVie Inc.

vs MSLE

Market Cap

$11.01M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

NMTC

NeuroOne Medical Technologies Corporation

vs MSLE

Market Cap

$9.92M

PE Ratio

N/A

TTM Avg

3.33

3Y Avg

3.33

5Y Avg

3.33

NAME	MARKET CAP	PE RATIO	TTM	3Y	5Y
Satellos Bioscience Inc. (MSLE)	$10.42M	N/A	N/A	N/A	N/A
Lifeward Ltd. (LFWD)vs ›	$10.47M	N/A	N/A	N/A	N/A
Lisata Therapeutics, Inc. (LSTA)vs ›	$11.38M	N/A	2.09	2.09	2.09
CytoMed Therapeutics Limited (GDTC)vs ›	$11.00M	N/A	N/A	N/A	N/A
Caring Brands, Inc. (CABR)vs ›	$10.09M	N/A	N/A	N/A	N/A
Medicus Pharma Ltd. Common Stock (MDCX)vs ›	$10.06M	N/A	N/A	N/A	N/A
MetaVia Inc. (MTVA)vs ›	$10.08M	N/A	N/A	N/A	N/A
Cerenome, Inc. (CNSY)vs ›	$10.98M	N/A	N/A	N/A	N/A
BioVie Inc. (BIVI)vs ›	$11.01M	N/A	N/A	N/A	N/A
NeuroOne Medical Technologies Corporation (NMTC)vs ›	$9.92M	N/A	3.33	3.33	3.33

P/E Comparison

Trailing P/E

N/A

Forward P/E

N/A

PE Ratio Formula & Definition

PE Ratio = Share Price / Diluted EPS (TTM)

The price-to-earnings ratio measures how much investors pay for each dollar of trailing earnings. A lower PE can indicate a cheaper valuation; a higher PE implies higher growth expectations.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

See the Lowest P/E Ratio Stocks ranking →

PE Ratio: N/A

MSLE PE Ratio Metrics

MSLE Competitors' PE Ratio

P/E Comparison

PE Ratio Formula & Definition

Related Metrics